Number of Polyploid Giant Cancer Cells and Expression of EZH2 Are Associated with VM Formation and Tumor Grade in Human Ovarian Tumor
Figure 4
EZH2 expression in human serous ovarian tumor cells and CAF. (a) EZH2 expression in human serous ovarian tumor cells. (A) EZH2 expression in borderline serous cystadenoma (IHC ×100). (B) EZH2 expression in human serous ovarian cancer cells without metastasis (IHC ×100). (C) EZH2 expression in human serous ovarian cancer cells with metastasis (IHC ×100). (D) EZH2 expression in the metastasis of human serous ovarian carcinoma; PGCCs are positive for EZH2 staining (black arrow, IHC ×200). (E) EZH2 expression in the PGCCs located in the boundary between tumor tissue and normal tissue (black arrow, IHC ×200). (b) EZH2 expression in the CAF of human serous ovarian tumor. (A) In group IV (black arrow, IHC ×200). (B) In group III (IHC ×200). (C) In group I (IHC ×200).
